`
`AFPFLICATION
`
`Untrep Stares PareENT AND TRADEMARK OFFIGE
`
`FILING or
`
`GRP ART
`
`UNTTED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Offier
`ove
`ba
`fAddiess. COMM ISSTONER FOR PATENTS
`wwe epto
`Alexandria.Aisbi 22915-1450
`
`NUMBER
`37 Lic) DATE
`UNIT
`FIL ——D
`ATTY.DOCKET.NO
`TOT CLAIMS IND CLAIMS
`
`61/915,113
`
`12/12/2013
`
`41188-720.101
`
`21971
`WILSON, SONSINI, GOODRICH & ROSATI
`
`£50 PAGE MILL ROAD
`
`PALO ALTO, GA 94304-1050
`
`CONFIRMATION NO. 4839
`
`FILING RECEIPT
`
`IHNNUM
`
`Date Mailed: 12/24/2013
`
`It will not be examined for patentability and will
`Receipt is acknowledged of this provisional patent application.
`become abandonednotlater than twelve monthsafterits filing date. Any correspondence concerning the application
`must include the following identification information: the U.S. APPLICATION NUMBER, FILING DATE, NAME OF
`APPLICANT, and TITLE OF INVENTION. Feestransmitted by checkor draft are subject to collection. Please verify
`the accuracy of the data presented on this receipt. If an error is noted on this Filing Receipt, please submit
`a written request for a Filing Receipt Correction. Please provide a copy of this Filing Receipt with the
`changes noted thereon. If you received a "Notice to File Missing Parts" for this application, please submit
`any correctionsto this Filing Receipt with your reply to the Notice. When the USPTO processesthereply
`to the Notice, the USPTO will generate another Filing Receipt incorporating the requested corrections
`
`Inventor(s)
`
`Euan THOMSON, San Francisco, CA;
`Nupur SRIVASTAVA, San Francisco, CA;
`Omar DAWOOD,San Francisco, CA;
`Iman ABUZEID, San Francisco, CA, CANADA;
`
`Applicant(s)
`
`AliveCOR, Inc., San Francisco, CA
`Power of Attorney:
`Darby Chan--62407
`
`Permission to Access - A proper Authorization to Permit Access to Application by Participating Offices
`(PTO/SB/39orits equivalent) has been received by the USPTO.
`
`lf Required, Foreign Filing License Granted: 12/17/2013
`The country code and numberof yourpriority application, to be usedforfiling abroad under the Paris Convention,
`is US 61/915,113
`Projected Publication Date: None, application is not eligible for pre-grant publication
`Non-Publication Request: No
`Early Publication Request: No
`** SMALL ENTITY **
`Title
`
`METHODS AND SYSTEMS FOR ARRHYTHMIA TRACKING AND SGORING
`
`Statement under 37 CFR 1.55 or 1.78 for AIA (First Inventor to File) Transition Applications: No
`page | of 3
`
`APPLE 1026
`
`APPLE 1026
`
`1
`
`

`

`PROTECTING YOUR INVENTION OUTSIDE THE UNITED STATES
`
`Since the rights granted by a U.S. patent extend only throughoutthe territory of the United States and have no
`effect in a foreign country, an inventor who wishes patent protection in another country must apply for a patent
`in a specific country or in regional patent offices. Applicants may wish to consider the filing of an international
`application under the Patent Cooperation Treaty (PCT). An international (PCT) application generally has the same
`effect as a regular national patent application in each PCT-member country. The PCT process simplifies the filing
`of patent applications on the sameinvention in member countries, but does not result in a grant of "an international
`patent" and doesnoteliminate the need of applicantstofile additional documents and fees in countries where patent
`protection is desired.
`
`Almost every country has its own patent law, and a person desiring a patent in a particular country must make an
`application for patent in that country in accordance with its particular laws. Since the laws of many countries differ
`in various respects from the patent law of the United States, applicants are advised to seek guidance from specific
`foreign countries to ensure that patent rights are not lost prematurely-
`
`Applicants also are advisedthat in the case of inventions madein the United States, the Director of the USPTO must
`issue a license before applicants can apply for a patent in a foreign country. The filing of a U.S. patent application
`serves as a request for a foreign filing license. The application's filing receipt contains further information and
`guidance asto the status of applicant's license for foreign filing.
`
`Applicants may wish to consult the USPTO booklet, "General Information Concerning Patents” (specifically, the
`section entitled "Treaties and Foreign Patents") for more information on timeframes and deadlinesfor filing foreign
`patent applications. The guide is available either by contacting the USPTO Contact Center at 800-786-9199, orit
`can be viewed on the USPTO website at http:/Awww.uspto.gov/web/offices/pac/doc/general/index.html.
`
`For information on preventing theft of your intellectual property (patents, trademarks and copyrights), you may wish
`to consult the U.S. Government website, http:/\www.stopfakes.gov. Part of a Department of Commerceinitiative,
`this website includes self-help "toolkits" giving innovators guidance on how to protectintellectual property in specific
`countries such as China, Korea and Mexico. For questions regarding patent enforcementissues, applicants may
`call the U.S. Government hotline at 1-866-999-HALT (1-866-999-4258),
`
`LICENSE FOR FOREIGN FILING UNDER
`
`Title 35, United States Code, Section 184
`
`Title 37, Code of Federal Regulations, 5.11 & 5.15
`
`GRANTED
`
`The applicant has been granted a license under 35 U.S.C. 184, if the phrase "IF REQUIRED, FOREIGN FILING
`LICENSE GRANTED”followed by a date appears on this form. Such licenses are issued in all applications where
`the conditions for issuance of a license have been met, regardless of whether or not a license may be required as
`set forth in 37 CFR 5.15. The scope andlimitations of this license are set forth in37 CFR 5.15(a) unless an earlier
`license has been issued under 37 CFR 5.15(b). The license is subject to revocation upon written notification. The
`date indicated is the effective date of the license, unless an earlierlicense of similar scope has been granted under
`37 CFR 5.13 or 5.14.
`
`page 2of 3
`
`2
`
`

`

`This license is to be retained by the licensee and may be used at any time on orafterthe effective date thereof unless
`itis revoked. This license is automatically transferred to any related applications(s) filed under 37 CFR 1.53(d). This
`license is not retroactive.
`
`Thegrantof a license does not in any way lessen the responsibility of a licensee for the security of the subject matter
`as imposed by any Government contract or the provisions of existing laws relating to espionage and the national
`security or the export of technical data. Licensees should apprise themselves of current regulations especially with
`respect to certain countries, of other agencies, particularly the Office of Defense Trade Controls, Department of
`State (with respect to Arms, Munitions and Implements of War (22 CFR 121-128)); the Bureau of Industry and
`Security, Department of Commerce (15 CFR parts 730-774); the Office of Foreign AssetsControl, Department of
`Treasury (31 CFR Parts 500+) and the Department of Energy.
`
`
`
`NOTGRANTED
`
`No license under 35 U.S.C. 184 has been granted at this time, if the phrase "IF REQUIRED, FOREIGN FILING
`LICENSE GRANTED" DOES NOTappear onthis form, Applicant maystill petition for a license under 37 CFR 5.12,
`if a license is desired before the expiration of 6 months from the filing date of the application. If 6 months has lapsed
`from thefiling date of this application and the licensee has not received any indication of a secrecy order under 35
`U.S.C. 181, the licensee may foreignfile the application pursuant to 37 CFR 5.15(b).
`
`
`
`SelectUSA
`
`The United States represents the largest, most dynamic marketplace in the world and is an unparalleled location for
`business investment, innovation, and commercialization of new technologies. The U.S.offers tremendous resources
`and advantages for those who invest and manufacture goods here. Through SelectUSA, our nation works to
`promote andfacilitate business investment. SelectUSA provides information assistanceto the international investor
`community; serves as an ombudsmanfor existing and potential investors; advocates on behalf of U.S.cities, states,
`and regions competing for global investment; and counsels U.S. economic developmentorganizations on investment
`attraction best practices. To learn more about why the United States is the best country in the world to develop
`technology, manufacture products, deliver services, and grow your business,visit http://www_SelectUSA.gov orcall
`+1-202-482-6800.
`
`page 3 of 3
`
`3
`
`

`

`PTO/SB/M16 (03-13)
`Approved for use through 01/31/2014, OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under he Paperwork Reduction Act of 1995, no persons.are required to respond fo a collection of information unlessit displays a valid OMB control number
`PROVISIONAL APPLICATION FOR PATENT COVER SHEET— Page 1 of 2
`This is a requestfor filing a PROVISIONAL APPLICATION FOR PATENT under 37 CFR 1.53(c),
`Express Mail Label No. N/A
`
`Additional inventors are being named on the
`
`separately numbered sheets attached hereto
`
`TITLE OF THE INVENTION(500 characters max):
`
`ABUZEID
`
`San Francisco, CA
`
`(<] The address corresponding to Customer Number:
`OR
`
`CORRESPONDENCE ADDRESS
`
`021971
`
`rs
`
`Firm or
`Individual Name
`Address
`
`city
`
`Zip
`
`Country
`
`Telephone
`ENCLOSED APPLICATION PARTS(checkall that opply)
`Application Data Sheet. See 37 CFR 1.76
`L] CD(s), Number of CDs
`7
`i] Drawing(s) Number of Sheets
`[| Other (specify)
`Specification (¢.g. description. of the invention) Number of Pages
`15
`
`Fees Due: Filing Fee of $260 ($130 for small entity) (S65 for micro entity). If the specification and drawings exceed 100 sheets of paper, an
`application size fee is also due, which is $400 ($200 for small entity) ($100 for micro entity) for each additional 50 sheets or fraction thereof.
`See 35 U.S.C. 41(a)(1)(G) and 37 CFR 1.16(s).
`METHOD OF PAYMENT OF THE FILING FEE AND APPLICATION SIZE FEE FOR THIS PROVISIONAL APPLICATION FOR PATENT
`
`METHODS AND SYSTEMS FOR ARRHYTHMIA TRACKING AND SCORING Direct all correspondence to;
`
`Applicant claims small entity status. See 37 CFR 1.27.
`
`[_] Applicantcertifiesmicroentitystatus.See37CFR 1.29,Ts130«|
`
`Applicant must attach form PTO/SB/15A or B or equivalent,
`
`A check or money order made payable to the Director of the United States Patent
`and Trademark Office is enclosed to cover the filing fee and applicationsize fee (if applicable),
`[| Payment by credit card, Form PTO-2038js attached
`x] The Director is hereby authorized to chargethefiling fee and application size fee (if applicable) or credit any overpayment to Deposit
`Account Number: 23-2415.
`
`TOTAL FEE AMOUNT (5)
`
`USE ONLY FOR FILING A PROVISIONAL APPLICATION FOR PATENT
`This collection of information is required by 37 CFR 1.51. The information is required to obtain or retain a benefit by the public which is to file (and by the USPTO to
`process) an application, Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1,11 and 1,14, This collection is estimated to take 10 hours to complete,including
`gathering, preparing, and submitting the completed application form to the USPTO. Time will vary depending uponthe individual case, Any comments on the
`amount of time you require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and
`Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450, DO NOT SEND FEES OR COMPLETED FORMSTO THIS ADDRESS, SEND
`TO; Commissionerfor Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
`Ifyou need assistance in completing the form, call 1-800-PTO-9199 and select option 2.
`
`5970091_1,doc
`
`4
`
`4
`
`

`

`PTO/SB/16 (03-13)
`Approved for use through 01/31/2014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1 995, no persons are required to respond lo a collection of information unless it displays a valid OMB control number.
`
`PROVISIONAL APPLICATION FOR PATENT COVER SHEET — Page2 of 2
`
`The invention was made by an agency of the United States Government or under a contract with an agency of the United States Government.
`BX] No
`CJ Yes, the invention was made by an agency of the U.S. Government. The U.S. Government agency nameis:
`
`[| Yes, the invention was made under a contract with an agency of the U.S. Government. The name of the U.S. Government agency and
`
`Government contract number are:
`
`WARNING:
`
`Petitioner/applicant is cautioned to avoid submitting personal information in documentsfiled in a patent application that may
`contribute to identity theft. Personal information such as social security numbers, bank account numbers, or credit card
`numbers(other than a check orcredit card authorization form PTO-2038 submitted for payment purposes)is never required by
`the USPTO to support a petition or an application. If this type of personal information is included in documents submitted to
`the USPTO,petitioners/applicants should consider redacting such personal information from the documents before submitting
`them to the USPTO. Petitioner/applicant is advised that the record of a patent application is available to the public after
`publication of the application (unless a non-publication request in compliance with 37 CFR 1.213(a) is made in the application)
`or issuarice of a patent. Furthermore, the record from an abandoned application may also be available to the public if the
`application is referenced in a published application or an issued patent (see 37 CFR 1.14). Checks and credit card authorization
`forms PTO-2038 submitted for payment purposes are not retained in the application file and therefore are not publicly
`available.
`
`SIGNATURE
`
`
`/Darby J. Chan/
`bate December 12, 2013
`
`TYPED or PRINTED NAME
`
`Darby J. Chan
`
`REGISTRATIONNO.
`(if appropriate)
`
`62,407
`
`TELEPHONE 650.493.9300
`
`Docket Number; 41188-720.101
`
`5970091 _1.doce
`
`5
`
`

`

`PTOMAIA/N14 (03-13)
`Approved for use through 01/31/2014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`Application Data Sheet 37 CFR 1.76
`
`—
`
`Title of Invention|METHODS AND SYSTEMS FOR ARRHYTHMIA TRACKING AND SCORING
`
`document may be printed and included in a paper filed application.
`
`The application data sheetis part of the provisional or nonprovisional application for whichit is being submitted. The following form contains the
`bibliographic data arranged in a format specified by the United States Patent and Trademark Office as outlined in 37 CFR 1.76.
`This document may be completed electronically and submitted to the Office in electronic format using the Electronic Filing System (EFS) or the
`
`Secrecy Order 37 CFR 5.2
`Oo Portions or all of the application associated with this Application Data Sheet may fall under a Secrecy Order pursuantto
`37 CFR 5.2 (Paperfilers only. Applications that fall under Secrecy Order may not be filed electronically.)
`
`
`
`Inventor Information:
`
`
`
`
`
`
`
`
`1
`
` Remove
`
`Inventor
`Legal Name
`
`
`
`
`Middle Name
`Family Name
` Prefix) Given Name
`
`
`
`
`() Active US Military Service
`©) NonUSResidency
`Residence Information (Select One} (e) US Residency
`
`
`State/Province Country of Residence i|US
`
`
`Mailing Addressof Inventor:
`
`Address 1
`
`30 Maiden Ln.
`
`Address 2
`
`City
`San Francisco
`State/Province
`| CA
`
`
`Inventor
`2
`Legal Name
`
`
`Nupur
`SRIVASTAVA
`Residence Information (Select One} (@) US Residency
`©) NonUSResidency
`() Active US Military Service
`
`Mailing Address of Inventor:
`
`Address 2
`
`30 Maiden Ln.
`Address 1
`
`
`Inventor
`Legal Name
`
`
`3
`
`Prefix) Given Name
`Middle Name
`Family Name
`Suffix
`for000 _
`Residence Information (Select One} (@) US Residency
`©) NonUSResidency ©) Active US Military Service
`
`EFS Web 2.2.8
`
`6
`
`6
`
`

`

`PTOMAIA/N14 (03-13)
`Approved for use through 01/31/2014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Underthe Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`Application Data Sheet 37 CFR 1.76
`
`METHODS AND SYSTEMS FOR ARRHYTHMIA TRACKING AND SCORING
`Title of Invention
`
`
`
`
`
`
`City|San Francisco | Country of Residencei | US | State/Province | CA
`
`Mailing Address of Inventor:
`
`Address 1
`
`30 Maiden Ln.
`
`4
`Inventor
`Legal Name
`
`Prefix) Given Name
`
`Middle Name
`
`Family Name
`
`Suffix
`
`
`
`() Active US Military Service
`©) NonUSResidency
`Residence Information (Select One} (@) US Residency
`
`
`City|San Francisco State/Province|CA Country of Residence!|CA
`
`
`
`Mailing Addressof Inventor:
`
`
`Address 1
`Address 2
`
`
`30 Maiden Ln.
`
`
`
`
`
`
`
`
`
`
`Inventor Information blocks may be
`Inventors Must Be Listed - Additional
`All
`
`generated within this form by selecting the Add button.
`
`
`
`
`
`
`
`CorrespondenceInformation:
`
`Enter either Gustomer Number or complete the Correspondence Information section below.
`For further information see 37 CFR 1.33(a).
`
`[| An Addressis being provided for the correspondenceInformation of this application.
`
`Customer Number
`
`21971
`
`Email Address
`
`|
`
`Add Email
`
`Application Information:
`
` METHODS AND SYSTEMS FOR ARRHYTHMIA TRACKING AND SCORING
`
`Title of the Invention
`
`
`
`Attorney Docket Number
`Small Entity Status Claimed
`Application Type
`
`
`
`Subject Matter
`
`
`
`
`
`Total Numberof Drawing Sheets (if any)/7_|SuggestedFigureforPublication(ifany)|_|
`
`
`
`
`
`
`EFS Web 2.2.8
`
`7
`
`7
`
`

`

`PTOMAIA/N14 (03-13)
`Approved for use through 01/31/2014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Underthe Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`
`
`oo Attorney Docket Number|41188-720.101
`
`Application Data Sheet 37 CFR 1.76
`—
`
`METHODS AND SYSTEMS FOR ARRHYTHMIA TRACKING AND SCORING
`Title of Invention
`
`
`Publication Information:
`
`[_] Request Early Publication (Fee required at time of Request 37 CFR 1.219)
`
`
`[]
`
`Req uest Not to Publish. | hereby request that the attached application not be published under
`35 U.S.C. 122(b) and certify that the invention disclosed in the attached application has not and will not be the
`subject of an applicationfiled in another country, or under a multilateral international agreement, that requires
`publication at eighteen monthsafterfiling.
`
`
`
`
`
`Representative Information:
`
`Representative information should be provided for all practitioners having a power of attorney in the application. Providing
`this information in the Application Data Sheet does not constitute a powerof attorney in the application (see 37 CFR 1.32).
`Either enter Customer Number or complete the Representative Name section below.
`If both sections are completed the customer
`Numberwill be used for the Representative Information during processing.
`
`
`©) Limited Recognition (37 CFR 11.9) Customer Number
`
`Please Select One:
`
`(@) Customer Number
`21971
`
`©) US PatentPractitioner
`
`Domestic Benefit/National Stage Information:
`This section allows for the applicant to either claim benefit under 35 U.S.C. 119(e), 120, 121, or 365(c) or indicate
`National Stage entry from a PCT application. Providing this information in the application data sheet constitutes the
`specific reference required by 35 U.S.C. 119(e) or 120, and 37 CFR 1.78.
`
`Application Number
`
`Continuity Type
`
`Prior Application Number
`
`Filing Date (YYYY-MM-DD})
`
`Additional Domestic Benefit/National Stage Data may be generated within this form
`by selecting the Add button.
`
`Ace
`
`This section allows for the applicant to claim priority to a foreign application. Providing this information in the application data sheet
`
`
`
`Foreign Priority Information:
`
`
`constitutes the claim for priority as required by 35 U.S.C. 119{b) and 37 CFR 1.55(d). When priority is claimed to a foreign application
`thatis eligible for retrieval uncer the priority cocument exchange program (PDX) ithe information will be used by the Office to
`automatically attempt retrieval pursuant to 37 CFR 1.55(h}{1) and (2). Under the PDX program, applicant bears the ultimate
`
`responsibility for ensuring that a copy of the foreign application is received by the Office from the participating foreign intellectual
`property office, or a certified copy of the foreign priority application is filed, within the time period specified in 37 CFR 1.55(g){1).
`
`
`
`
`Access Code (if applicable)
`Filing Date (YYYY-MM-DD)
`
`Application Number
`Country i
`
`
`Additional Foreign Priority Data may be generated within this form by selecting the
`Add button.
`EFS Web 2.2.8
`
`8
`
`
`
`8
`
`

`

`PTOMAIA/N14 (03-13)
`Approved for use through 01/31/2014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Underthe Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`icati
`
`Application Data Sheet 37 CFR 1.76
`
`METHODS AND SYSTEMS FOR ARRHYTHMIA TRACKING AND SCORING
`Title of Invention
`
`
`Statement under 37 CFR 1.55 or 1.78 for AIA (First Inventor to File) Transition
`Applications
`
`This application (1) claims priority to or the benefit of an application filed before March 16, 2013 and (2) also
`contains, or contained at any time, a claim to a claimed invention that has an effective filing date on or after March
`[|16, 2013.
`NOTE: Byproviding this statement under 37 CFR 1.55 or 1.78, this application, with a filing date on or after March
`
`16, 2013, will be examined underthe first inventor to file provisions of the AIA.
`
`Authorization to Permit Access:
`
`Authorization to Permit Access to the Instant Application by the Participating Offices
`
`If checked, the undersigned hereby grants the USPTO authority to provide the European Patent Office (EPO),
`the Japan Patent Office (JP©), the Korean Intellectual Property Office (KIPO), the World Intellectual Property Office (WIPO),
`and any otherintellectual property offices in which a foreign application claiming priority to the instant patent application
`is filed access to the instant patent application. See 37 CFR 1.14(c) and (h). This box should not be checkedif the applicant
`does not wish the EPO, JPO, KIPO, WIPO, or otherintellectual property office in which a foreign application claiming priority
`to the instant patent application is filed to have accessto the instant patent application.
`
`In accordance with 37 CFR 1.14(h){3), access will be provided to a copy of the instant patent application with respect
`to: 1) the instant patent application-as-filed; 2) any foreign application to which the instant patent application
`claims priority under 35 U.S.C. 119{a)-{c) if a copy of the foreign application that satisfies the certified copy requirement of
`3/7 CFR 1.55 has beenfiled in the instant patent application; and 3) any U.S. application-as-filed from which benefit is
`soughtin the instant patent application.
`
`In accordance with 37 CFR 1.14(c}, access may be provided to information concerning the date offiling this Authorization.
`
`
`
`
`
`Applicant Information:
`
`Providing assignmentinformation in this section does not substitute for compliance with any requirement of part 3 of Title 37 of CFR
`
`to have an assignment recorded by the Office.
`
`EFS Web 2.2.8
`
`9
`
`9
`
`

`

`PTOMAIA/N14 (03-13)
`Approved for use through 01/31/2014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Underthe Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`icati
`
`Application Data Sheet 37 CFR 1.76
`
`METHODS AND SYSTEMS FOR ARRHYTHMIA TRACKING AND SCORING
`Title of Invention
`
`
`1
`Applicant
`If the applicant is the inventor (or the remaining joint inventor or inventors under 37 CFR 1.45), this section should not be completed.
`The information to be provided in this section is the name and addressof the legal representative who is the applicant under 37 CFR
`1.43; or the name and addressof the assignee, person to whom theinventor is under an obligation to assign the invention, or person
`who otherwise showssufficient proprietary interest in the matter who is the applicant uncer 37 CFR 1.46. If the applicant is an
`applicant under 37 CFR 1.46 {assignee, person to whom the inventoris obligated to assign, or person who otherwise showssufficient
`proprietary interest) together with one or morejoint inventors, then the joint inventor or inventors who are also the applicant should be
`identified in this section.
`
`(e) Assignee
`
`QC) Legal Representative under 35 U.S.C. 117
`
`Joint Inventor
`
`Email Address Additional Applicant Data may be generated within this form by selecting the Add button.
`
`Person who shows sufficient proprietary interest C)
`
`QO Person to whom the inventoris obligated to assign.
`
`CO
`
`lf applicant is the legal representative, indicate the authority to file the patent application, the inventoris:
`
`Nameof the Deceased or Legally Incapacitated Inventor:
`
`If the Applicant is an Organization check here.
`
`Organization Name
`
`AliveCOR, Inc.
`
`Mailing Address Information:
`
`Address 1
`
`Address 2
`
`City
`Country i} us
`
`30 Maiden Ln.
`
`San Francisco
`
`State/Province
`Postal Code
`
`CA
`94108
`
`Add
`
`
`
`
`Assignee Information including Non-Applicant Assignee Information:
`
`Providing assignment information in this section does not subsitute for compliance with any requirementof part 3 of Title 37 of CFR to
`have an assignmentrecorded by the Office.
`
`
`
`Assignee
`
`1
`
`Complete this section if assignee information, including non-applicant assignee information, is desired to be included on the patent
`application publication . An assignee-applicant identified in the "Applicant Information" section will appear on the patent application
`publication as an applicant. For an assignee-applicant, complete this section only if identification as an assigneeis also desired on the
`patent application publication.
`
`Remove
`
`If the Assignee is an Organization check here.
`
`|
`
`EFS Web 2.2.8
`
`10
`
`10
`
`

`

`PTOMAIA/N14 (03-13)
`Approved for use through 01/31/2014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Underthe Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`icati
`
`Application Data Sheet 37 CFR 1.76
`
`Title of Invention
`
`METHODS AND SYSTEMS FOR ARRHYTHMIA TRACKING AND SCORING
`
`
`
`
`
`Mailing Address Information:
`
`
`Address 1
`
`Address 2
`
`
`City
`State/Province
`
`
`Country ji
`
`Postal Code
`
`Email Address
`
`Additional Assignee Data may be generated within this form by selecting the Add button.
`
`add
`
`Signature:
`
`NOTE: This form must be signed in accordance with 37 CFR 1.33. See 37 CFR 1.4 for signature requirements and
`certifications
`
`
`
`
`
`
`
`
`
`
`Signature
`
`{Darby J. Chan/
`
`First Name
`
`Date (YYYY-MM-DD)|
`
`2013-12-12
`
`Additional Signature may be generated within this form by selecting the Add button.
`
`This collection of information is required by 37 CFR 1.76. The information is required to obtain or retain a benefit by the public which
`is to file (and by the USPTOto process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.14. This
`collection is estimated to take 23 minutes to complete, including gathering, preparing, and submitting the completed application data
`sheet form to the USPTO. Time will vary depending upon the individual case. Any comments on the amountof time you require to
`complete this form and/or suggestions for reducing this burden, should be sentto the Chief Information Officer, U.S. Patent and
`Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR
`COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
`
`EFS Web 2.2.8
`
`11
`
`11
`
`

`

`
`
`Privacy Act Statement
`
`The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection with your submission of the attached form related to
`a patent application or patent. Accordingly, pursuant to the requirements of the Act, please be advised that:
`(1) the general authority for the collection
`of this information is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited is voluntary; and (3) the principal purpose for which the information is
`used by the U.S. Patent and Trademark Office is to process and/or examine your submission related to a patent application or patent.
`If you do not
`furnish the requested information, the U.S. Patent and Trademark Office may not be able to process and/or examine your submission, which may
`result in termination of proceedings or abandonmentof the application or expiration of the patent.
`
`The information provided by you in this form will be subject to the following routine uses:
`
`1.
`
`The information on this form will be treated confidentially to the extent allowed under the Freedom of Information Act (5 U.S.C. 552)
`and the Privacy Act (5 U.S.C. 552a). Records from this system of records may be disclosed to the Department of Justice to determine
`whether the Freedom of Information Act requires disclosure of these records.
`
`A record from this system of records may be disclosed, as a routine use, in the course of presenting evidence to a court, magistrate, or
`administrative tribunal, including disclosures to opposing counsel in the course of settlement negotiations.
`
`A record in this system of records may be disclosed, as a routine use, to a Memberof Congress submitting a request invalving an
`individual, to whom the record pertains, when the individual has requested assistance from the Memberwith respect to the subject matter of
`the record.
`
`A record in this system of records may be disclosed, as a routine use, to a contractor of the Agency having need for the information in
`order to perform a contract. Recipients of information shall be required to comply with the requirements of the Privacy Act of 1974, as
`amended, pursuant to 5 U.S.C. 552a(m).
`
`A record related to an International Application filed under the Patent Cooperation Treaty in this system of records maybe disclosed,
`as a routine use, to the International Bureau of the World Intellectual Property Organization, pursuant to the Patent Cooperation Treaty.
`
`A record in this system of records may be disclosed, as a routine use, to another federal agency for purposes of National Security
`review (35 U.S.C. 181) and for review pursuant to the Atomic Energy Act (42 U.S.C. 218(c)).
`
`A record from this system of records may be disclosed, as a routine use, to the Administrator, General Services, or his/her designee,
`during an inspection of records conducted by GSA as part of that agency's responsibility to recommend improvements in records
`management practices and programs, under authority of 44 U.S.C. 2904 and 2906. Such disclosure shall be made in accordance with the
`GSA regulations governing inspection of records for this purpose, and any other relevant (i.e., GSA or Commerce) directive. Such
`disclosure shall not be used to make determinations aboutindividuals.
`
`A record from this system of records may be disclosed, as a routine use, to the public after either publication of the application pursuan
`te 35 U.S.C. 122(b) or issuance of a patent pursuant to 35 U.S.C. 151. Further, a record may be disclosed, subject to the limitations of 37
`CFR 1.14, as a routine use, to the public if the record wasfiled in an application which became abandonedorin which the proceedings were
`terminated and which application is referenced by either a published application, an application open to public inspections or an issued
`patent.
`
`A record from this system of records may be disclosed, as a routine use, to a Federal, State, or local law enforcement agency,if the
`USPTO becomes aware of a violation or potential violation of law or regulation.
`
`EFS Web 2.2.8
`
`
`
`12
`
`

`

`ABSTRACT OF THE DISCLOSURE
`
`A dashboard centered around arrhythmia or A-fib tracking is provided. The dashboard
`
`includes a heart or cardiac health score that can be calculated in response to data from the user such
`
`as their ECG and other personal information and cardiac health influencing factors. The dashboard
`
`also provides to the user recommendationsorgoals, such as daily goals, for the user to meet and
`
`thereby improvetheir heart or cardiac health score. These goals and recommendations maybeset
`
`by the user or a medical professional and routinely updated as his or her heart or cardiac health score
`
`improves or otherwise changes. The dashboard is generally displayed from an application provided
`
`on a smartphoneortablet computer of the user.
`
`S97()122_